| # | Drug | Count |
|---|---|---|
| 0 | FUROSEMIDE | 20 |
| 1 | TACROLIMUS | 17 |
| 2 | ASPIRIN | 13 |
| 3 | ASPIRIN 325 MG | 13 |
| 4 | ASPIRIN 81 MG | 13 |
| 5 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 13 |
| 6 | TACROLIMUS OINTMENT 0.1% | 13 |
| 7 | BISOPROLOL FUMARATE | 12 |
| 8 | APIXABAN | 11 |
| 9 | CLOPIDOGREL BISULFATE | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | 1 | 0.0156 |
| 1 | FLAVOXATE HYDROCHLORIDE | 1 | 0.0099 |
| 2 | SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE | 1 | 0.0013 |
| 3 | DEXCHLORPHENIRAMINE MALEATE | 1 | 0.0010 |
| 4 | BASILIXIMAB | 10 | 0.0008 |
| 5 | GINKGO BILOBA | 1 | 0.0007 |
| 6 | METHYLENE BLUE | 1 | 0.0006 |
| 7 | CASPOFUNGIN ACETATE | 1 | 0.0006 |
| 8 | GLUTATHIONE | 1 | 0.0006 |
| 9 | ISOSORBIDE MONONITRATE | 10 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 23 |
| 1 | Loop Diuretic [EPC] | 22 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 16 |
| 3 | Factor Xa Inhibitor [EPC] | 13 |
| 4 | Nitrate Vasodilator [EPC] | 13 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 13 |
| 6 | Platinum-based Drug [EPC] | 13 |
| 7 | Kinase Inhibitor [EPC] | 12 |
| 8 | Microtubule Inhibitor [EPC] | 12 |
| 9 | P2Y12 Platelet Inhibitor [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 1 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 2 | 0.0003 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 6 | 0.0003 |
| 3 | Ergot Derivative [EPC] | 1 | 0.0002 |
| 4 | Provitamin D2 Compound [EPC] | 5 | 0.0002 |
| 5 | Nitrate Vasodilator [EPC] | 13 | 0.0001 |
| 6 | Somatostatin Analog [EPC] | 1 | 0.0001 |
| 7 | Calcitonin Gene-related Peptide Receptor Antagonist [EPC] | 1 | 0.0001 |
| 8 | Cannabinoid [EPC] | 1 | 0.0001 |
| 9 | Cephalosporin Antibacterial [EPC] | 1 | 0.0001 |